Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma

Clinical Endocrinology

Volumn 78, Issue 4, 2013, Pages 614-620

  Kim, Sun Wook ^a   Kim, Hye Jeong ^a   Kim, Na Kyung ^a   Choi, Ji Hun ^a   Kim, Se Won ^a   Jin, Sang Man ^a   Suh, Sunghwan ^a   Bae, Ji Cheol ^a   Min, Yong Ki ^a   Chung, Jae Hoon ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ABLATION THERAPY; ADULT; ARTICLE; CANCER RECURRENCE; CERVICAL LYMPH NODE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PAPILLARY THYROID MICROCARCINOMA; PRIORITY JOURNAL; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREVALENCE; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875138511     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12034     Document Type: Article

References (25)

1. Hedinger, C., Wiliams, E.D., &, Sobin, L.H., (1988) Histologic Typing of Thyroid Tumors. International Histological Classification of Tumors, no.11. World Health Organization, Geneva, 1-18.
2. Davies, L., &, Welch, H.G., (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA, 295, 2164-2167.
3. Baudin, E., Travagli, J.P., Ropers, J., et al,. (1998) Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer, 83, 553-559.
4. Bernet, V., (2010) Approach to the patient with incidental papillary microcarcinoma. Journal of Clinical Endocrinology and Metabolism, 95, 3586-3592.
5. Arora, N., Turbendian, H.K., Kato, M.A., et al,. (2009) Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid, 19, 473-477.
6. Cheema, Y., Repplinger, D., Elson, D., et al,. (2006) Is tumor size the best predictor of outcome for papillary thyroid cancer? Annals of Surgical Oncology, 13, 1524-1528.
7. Cooper, D.S., Doherty, G.M., Haugen, B.R., et al,. (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19, 1167-1214.
8. Pacini, F., Schlumberger, M., Dralle, H., et al,. (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology, 154, 787-803.
9. Hay, I.D., Hutchinson, M.E., Gonzalez-Losada, T., et al,. (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery, 144, 980-987; discussion 987-988.
10. Ross, D.S., Litofsky, D., Ain, K.B., et al,. (2009) Recurrence after treatment of micropapillary thyroid cancer. Thyroid, 19, 1043-1048.
11. Byar, D.P., Green, S.B., Dor, P., et al,. (1979) A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. European Journal of Cancer, 15, 1033-1041.
12. Hay, I.D., Bergstralh, E.J., Goellner, J.R., et al,. (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery, 114, 1050-1057; discussion 1057-1058.
13. Chow, S.M., Law, S.C., Chan, J.K., et al,. (2003) Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer, 98, 31-40.
14. AJCC (American Joint Committee on Cancer). (2010) Thyroid. In:, S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, A. Trotti, eds. Cancer Staging Manual, 7th edn. Springer-Verlag, New York, 87-96.
15. Curtis, L.H., Hammill, B.G., Eisenstein, E.L., et al,. (2007) Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Medical Care, 45, S103-S107.
16. Sugihara, M., (2010) Survival analysis using inverse probability of treatment weighted methods based on the generalized propensity score. Pharmaceutical Statistics, 9, 21-34.
17. Lim, D.J., Baek, K.H., Lee, Y.S., et al,. (2007) Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma. Thyroid, 17, 883-888.
18. Creach, K.M., Siegel, B.A., Nussenbaum, B., et al,. (2012) Radioactive iodine therapy decreases recurrence in thyroid papillary microcarcinoma. ISRN Endocrinology, 2012, 816386.
19. Pelizzo, M.R., Boschin, I.M., Toniato, A., et al,. (2006) Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. European Journal of Surgical Oncology, 32, 1144-1148.
20. Lin, H.W., &, Bhattacharyya, N., (2009) Survival impact of treatment options for papillary microcarcinoma of the thyroid. Laryngoscope, 119, 1983-1987.
21. Hay, I.D., Thompson, G.B., Grant, C.S., et al,. (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World Journal of Surgery, 26, 879-885.
22. Brown, A.P., Chen, J., Hitchcock, Y.J., et al,. (2008) The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 93, 504-515.
23. Lang, B.H., Wong, I.O., Wong, K.P., et al,. (2012) Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy. Surgery, 151, 844-850.
24. Zettinig, G., Hanselmayer, G., Fueger, B.J., et al,. (2002) Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study. European Journal of Nuclear Medicine and Molecular Imaging, 29, 1428-1432.
25. Kloos, R.T., Duvuuri, V., Jhiang, S.M., et al,. (2002) Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 87, 5817-5820.